Acetylcholine (ACh) signaling is a well-studied pathway in the neuromuscular junction (NMJ), but its role in the nervous system is poorly characterized. Rapsyn is a 43-kD protein that clusters and anchors acetylcholine receptors (AChR) in the postsynaptic membrane of the NMJ. Mutations in rapsyn have been associated with neuromuscular diseases in humans. For example, the N88K mutation in the RAPSN gene causes congenital myasthenic syndrome (1). In mice, targeted disruption of the RAPSN gene causes death within a few hours of birth (2). In C. elegans, however, rapsyn-1 (
rpy-1) mutants are viable and appear wildtype in their locomotory ability. We plan to combine genetics and behavioral analysis to understand the role of
rpy-1 in the worm.
We find that
rpy-1 mutants display a gain-of-function behavioral phenotype in the local search assay. They make twice as many turns in the first 15 minutes off food when compared to N2 wildtype animals. In order to test where
rpy-1 functions, we performed knockdown experiments by expressing sense and antisense
rpy-1 transcripts in muscles or in neurons. Surprisingly, neuronal knockdowns of
rpy-1 are similar to
rpy-1 mutants, while muscle knockdowns appear wildtype. This suggests that
rpy-1 is required in the neurons rather than in the muscle. We will use transgenic rescue experiments to identify the cellular sites of
rpy-1 action. We also plan on using candidate gene mutants and biochemical methods to identify components of the
rpy-1 signaling pathway. These studies will provide insights into ACh signaling in the nervous system.
(1) Dunne, V., Maselli, R. A., Hum. Genet. 49: 366-369 (2004)
(2) Gautam, M., et al., Nature 377: 232-236 (1995).